[1]
Khurana, M.; Rahman, S.O.; Najmi, A.K.; Pottooc, F.H.; Akhtar, M.S. Application of Contemporary Neuroproteomic Techniques in Unravelling Neurological Disorders. Curr. Protein Pept. Sci., 2020, 21(12), 1146-1163.
[2]
Narayanan, S.E.; Sekhar, N.; Rajamma, R.G.; Marathakam, A.; Al Mamun, A.; Uddin, M.S.; Mathew, B. Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer’s Disease. Curr. Protein Pept. Sci., 2020, 21(12), 1164-1173.
[3]
Puranik, N.; Yadav, D.; Yadav, S.K.; Chavda, V.K. -O. Jin, J. Proteomics and neurodegenerative disorders: Advancements in the diagnostic analysis. Curr. Protein Pept. Sci., 2020, 21(12), 1174-1183.
[4]
Shaikh, S.; Nazam, N.; Rizvi, S.M.D.; Hussain, T.; Farhana, A.; Choi, I. Anti-Amyloid Aggregating Gold Nanoparticles: Can they Really be Translated from Bench to Bedside for Alzheimer’s Disease Treatment? Curr. Protein Pept. Sci., 2020, 21(12), 1184-1192.
[5]
Al Mamun, A.; Rahman, M.M.; Zaman, S.; Munira, M.S.; Uddin, M.S.; Rauf, A.; Banu, N.; Ashraf, G.M. Molecular Insight into the Crosstalk of UPS Components and Alzheimer’s Disease. Curr. Protein Pept. Sci., 2020, 21(12), 1193-1201.
[6]
Li, K.; Chen, Z.; Yang, X.; Zhang, Y. Applications of iTRAQ and TMT Labeling Techniques to the Study of Neurodegenerative Diseases. Curr. Protein Pept. Sci., 2020, 21(12), 1202-1217.
[7]
Kumar, S.; Singh, P.; Sharma, S.; Ali, J.; Baboota, S.; Pottoo, F.H. Proteomic Analysis of Huntington’s Disease. Curr. Protein Pept. Sci., 2020, 21(12), 1218-1222.
[8]
Bergantin, L.B. The Interplay Between Depression and Parkinson’s Disease: Learning the Link Through Ca2+/cAMP Signaling. Curr. Protein Pept. Sci., 2020, 21(12), 1223-1228.
